$5.27
7.55%
Nasdaq, Mon, Nov 25 2024
ISIN
US72940R1023
Symbol
PSTI
Sector
Industry

Pluristem Therapeutics Inc. Target price 2024 - Analyst rating & recommendation

Pluristem Therapeutics Inc. Classifications & Recommendation:

Hold
100%

Pluristem Therapeutics Inc. Price Target

Target Price $24.00
Price $5.27
Potential
Number of Estimates 1
1 Analyst has issued a Pluristem Therapeutics Inc. price target 2025. The average Pluristem Therapeutics Inc. target price is $24.00. This is higher than the current stock price.
A rating was issued by 1 analysts: 0 Analysts recommend Pluristem Therapeutics Inc. to buy, 1 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Pluristem Therapeutics Inc. stock has an average upside potential 2025 of . Most analysts recommend the Pluristem Therapeutics Inc. stock at Hold.

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today